Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Drugs for Neglected Diseases Initiative (Dndi)
Headquarters: Geneva, Switzerland
Website: http://www.dndi.org
Year Founded: 2003
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Apr 21, 2022
Politics, Policy & Law
WHO says Pfizer should do more to create global access to COVID antiviral
The pharma says it’s been committed to broad access from the start and continues to respond to global needs
BioCentury | Jul 22, 2021
Deals
July 21 Quick Takes: Turnstone’s $80M round to advance oncolytic virus, TIL programs
Plus: Vedanta, bluebird, Cytokinetics and more
BioCentury | Apr 25, 2020
Deals
Novartis business development stays on course during COVID-19
Novartis, NIBR continuing full steam ahead to find partnering opportunities, COVID notwithstanding
BioCentury | Apr 17, 2019
Preclinical News
Atomwise unveils Chagas disease compounds from AIMS program
BioCentury | Sep 8, 2017
Finance
Antibiotic engine
Entasis taps non-dilutive and series B-1 funds to advance antibiotics trio
Items per page:
1 - 10 of 30